Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1261 entries
Sorted by: Best Match Show Resources per page
Gender-specific HIV prevention interventions for women who use alcohol and other drugs: the evolution of the science and future directions

Science interventions

Wechsberg WM, Myers B.
GSID: JsklnkGYhPAJ
WM Wechsberg, S Deren, B Myers… - Journal of acquired …, 2015 - ncbi.nlm.nih.gov

… interventions, explores the challenges to delivering these interventions, and discusses directions in which these … interventions that met the criteria for second-generation women-focused interventions for women who use AODs, which also included couple-focused interventions …

Cite
Wechsberg, W. M., Deren, S., Myers, B., Kirtadze, I., Zule, W. A., Howard, B., & El-Bassel, N. (2015). Gender-specific HIV prevention interventions for women who use alcohol and other drugs: the evolution of the science and future directions. Journal of acquired immune deficiency syndromes (1999), 69(0 1), S128.
Wechsberg, Wendee M., et al. "Gender-specific HIV prevention interventions for women who use alcohol and other drugs: the evolution of the science and future directions." Journal of acquired immune deficiency syndromes (1999) 69.0 1 (2015): S128.
Copy Download .nbib Format: MLA
STEM Skills Initiatives for Adolescent Girls in the LAC Region

STEM and girls

Myers C.
GSID: YmfxMshcZ6EJ
X Villavicencio, C Myers, CM Coflan - 2022 - docs.edtechhub.org

This report was produced in response to a request from the UNICEF country office of Argentina and presents a curated list of science, technology, engineering, and mathematics (STEM) skills initiatives for adolescent girls in the Latin American and Caribbean...

Cite
Villavicencio, X., Myers, C., & Coflan, C. M. (2022). STEM Skills Initiatives for Adolescent Girls in the LAC Region (No. 42). EdTech Hub.
Villavicencio, Xuzel, Christina Myers, and Caitlin Moss Coflan. STEM Skills Initiatives for Adolescent Girls in the LAC Region. No. 42. EdTech Hub, 2022.
Copy Download .nbib Format: MLA
How designers design and program interactive behaviors

program design

Myers B, Park SY.
GSID: 6DA2mRjKIikJ
B Myers, SY Park, Y Nakano… - 2008 IEEE Symposium …, 2008 - ieeexplore.ieee.org

… Communicating the design of behaviors to developers was reported to be more difficult than the appearance by 76% of the designers in our study. 5. As reported for other kinds of design [4, 9, 17], the designers in...

Cite
Myers, B., Park, S. Y., Nakano, Y., Mueller, G., & Ko, A. (2008, September). How designers design and program interactive behaviors. In 2008 IEEE Symposium on Visual Languages and Human-Centric Computing (pp. 177-184). IEEE.
Myers, Brad, et al. "How designers design and program interactive behaviors." 2008 IEEE Symposium on Visual Languages and Human-Centric Computing. IEEE, 2008.
Copy Download .nbib Format: MLA
How Designers Design and Prototype Interactive Behaviors

program design

Myers B, Park SY.
GSID: ZZgEaN5eB-MJ
B Myers, SY Park, Y Nakano, G Mueller, A Ko - cs.cmu.edu

Designers are skilled at sketching and prototyping the look of interfaces, but to explore various behaviors (what the interface does) typically requires writing scripting code using …

Cite
Myers, B., Park, S. Y., Nakano, Y., Mueller, G., & Ko, A. How Designers Design and Prototype Interactive Behaviors.
Myers, Brad, et al. "How Designers Design and Prototype Interactive Behaviors."
Copy Download .nbib Format: MLA
A set of principles for conducting and evaluating interpretive field studies in information systems

case studies

Myers MD.
GSID: eAV-lT11adsJ
HK Klein, MD Myers - MIS quarterly, 1999 - JSTOR

… While the conventions for evaluating information systems case studies conducted according to the natural science model of … case studies conducted according to the natural science model of social science are now widely accepted, this is not the...

Cite
Klein, H. K., & Myers, M. D. (1999). A set of principles for conducting and evaluating interpretive field studies in information systems. MIS quarterly, 67-93.
Klein, Heinz K., and Michael D. Myers. "A set of principles for conducting and evaluating interpretive field studies in information systems." MIS quarterly (1999): 67-93.
Copy Download .nbib Format: MLA
The legal duty to participate in continuing professional education.

Pharmacy management combined with the American journal of pharmacy : PM

Fink JL, Myers MJ.
PMID: 556410
Pharm Manage Comb Am J Pharm. 1979 Nov-Dec;151(6):281-4.

No abstract available.

Cite
Fink JL, Myers MJ. The legal duty to participate in continuing professional education. Pharm Manage Comb Am J Pharm. 1979;151(6):281-4
Fink, J. L., & Myers, M. J. (1979). The legal duty to participate in continuing professional education. Pharmacy management combined with the American journal of pharmacy : PM, 151(6), 281-4.
Fink, J L, and Myers, M J. "The legal duty to participate in continuing professional education." Pharmacy management combined with the American journal of pharmacy : PM vol. 151,6 (1979): 281-4.
Fink JL, Myers MJ. The legal duty to participate in continuing professional education. Pharm Manage Comb Am J Pharm. 1979 Nov-Dec;151(6):281-4. PMID: 556410.
Copy Download .nbib Format: NLM
Cephalhæmatoma Externum and Meningocele.

Proceedings of the Royal Society of Medicine

Myers B.
PMID: 20913438
Proc R Soc Med. 1932 Dec;26(2):138.

No abstract available.

Cite
Myers B. Cephalhæmatoma Externum and Meningocele. Proc R Soc Med. 1932;26(2):138
Myers, B. (1932). Cephalhæmatoma Externum and Meningocele. Proceedings of the Royal Society of Medicine, 26(2), 138.
Myers, B. "Cephalhæmatoma Externum and Meningocele." Proceedings of the Royal Society of Medicine vol. 26,2 (1932): 138.
Myers B. Cephalhæmatoma Externum and Meningocele. Proc R Soc Med. 1932 Dec;26(2):138. PMID: 20913438.
Copy Download .nbib Format: NLM
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open forum infectious diseases

Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R.
PMID: 25734170
Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec.

BACKGROUND: Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs.METHODS: A multicenter, randomized, blinded...

Cite
Mulligan MJ, Bernstein DI, Frey S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014;1(3):ofu102doi: 10.1093/ofid/ofu102.
Mulligan, M. J., Bernstein, D. I., Frey, S., Winokur, P., Rouphael, N., Dickey, M., Edupuganti, S., Spearman, P., Anderson, E., Graham, I., Noah, D. L., Mangal, B., Kim, S., Hill, H., Whitaker, J., Emery, W., Beck, A., Stephens, K., Hartwell, B., Ogilvie, M., Rimann, N., Osinski, E., Destefano, E., Gajadhar, T., Strudwick, A., Pierce, K., Lai, L., Yue, L., Wang, D., Ying, C., Cline, A., Foltz, T., Wagner, N., Dull, G., Pacatte, T., Taggart, B., Johnson, V., Haller, L., Looney, C., Li, S., May, M., Myers, B., May, R., Parker, L., Cochran, N., Bowen, D., Bell, M., Scoggins, J., Burns, A., Stablein, C., Wolff, M., Jolles, B., Leung, B., Lambert, L., Shorer, S., Buchanan, W., Murray, S., Chang, S., & Gorman, R. (2014). Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open forum infectious diseases, 1(3), ofu102. https://doi.org/10.1093/ofid/ofu102
Mulligan, Mark J, et al. "Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial." Open forum infectious diseases vol. 1,3 (2014): ofu102. doi: https://doi.org/10.1093/ofid/ofu102
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec. PMID: 25734170; PMCID: PMC4324215.
Copy Download .nbib Format: NLM
A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease.

Clinical kidney journal

Tan SJ, Ducharlet K, Dwyer KM, Myers D, Langham RG, Hill PA.
PMID: 26064494
Clin Kidney J. 2013 Jun;6(3):322-6. doi: 10.1093/ckj/sft043.

In diabetic patients with acute kidney injury (AKI), kidney biopsy often reveals non-diabetic kidney pathology. This case describes a patient with known Type 1 diabetes who presented with AKI, nephrotic syndrome and haematuria. Combination pathology of seronegative anti-glomerular basement...

Cite
Tan SJ, Ducharlet K, Dwyer KM, et al. A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease. Clin Kidney J. 2013;6(3):322-6doi: 10.1093/ckj/sft043.
Tan, S. J., Ducharlet, K., Dwyer, K. M., Myers, D., Langham, R. G., & Hill, P. A. (2013). A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease. Clinical kidney journal, 6(3), 322-6. https://doi.org/10.1093/ckj/sft043
Tan, Sven-Jean, et al. "A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease." Clinical kidney journal vol. 6,3 (2013): 322-6. doi: https://doi.org/10.1093/ckj/sft043
Tan SJ, Ducharlet K, Dwyer KM, Myers D, Langham RG, Hill PA. A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease. Clin Kidney J. 2013 Jun;6(3):322-6. doi: 10.1093/ckj/sft043. PMID: 26064494; PMCID: PMC4400487.
Copy Download .nbib Format: NLM
Clinical competence and EBP: An educator's perspective.

Nursing management

Wong P, Myers M.
PMID: 26201041
Nurs Manage. 2015 Aug;46(8):16-8. doi: 10.1097/01.NUMA.0000469358.02437.67.

No abstract available.

Cite
Wong P, Myers M. Clinical competence and EBP: An educator's perspective. Nurs Manage. 2015;46(8):16-8doi: 10.1097/01.NUMA.0000469358.02437.67.
Wong, P., & Myers, M. (2015). Clinical competence and EBP: An educator's perspective. Nursing management, 46(8), 16-8. https://doi.org/10.1097/01.NUMA.0000469358.02437.67
Wong, Paul, and Myers, Mary. "Clinical competence and EBP: An educator's perspective." Nursing management vol. 46,8 (2015): 16-8. doi: https://doi.org/10.1097/01.NUMA.0000469358.02437.67
Wong P, Myers M. Clinical competence and EBP: An educator's perspective. Nurs Manage. 2015 Aug;46(8):16-8. doi: 10.1097/01.NUMA.0000469358.02437.67. PMID: 26201041.
Copy Download .nbib Format: NLM
Large Group Exposure Treatment: A Feasibility Study of Exposure Combined with Diaphragmatic Breathing in Highly Dental Fearful Individuals.

Frontiers in psychology

Wannemueller A, Jöhren HP, Borgstädt A, Bosch J, Meyers M, Völse M, Scholten S, Margraf J.
PMID: 28111556
Front Psychol. 2017 Jan 06;7:2007. doi: 10.3389/fpsyg.2016.02007. eCollection 2016.

A large-group one session treatment (LG-OST) combining exposure and diaphragmatic breathing as a bodily coping element was carried out to investigate its feasibility and effectiveness in a sample of 43 highly dental fearful individuals treated simultaneously. We assessed subjective...

Cite
Wannemueller A, Jöhren HP, Borgstädt A, et al. Large Group Exposure Treatment: A Feasibility Study of Exposure Combined with Diaphragmatic Breathing in Highly Dental Fearful Individuals. Front Psychol. 2017;7:2007doi: 10.3389/fpsyg.2016.02007.
Wannemueller, A., Jöhren, H. P., Borgstädt, A., Bosch, J., Meyers, M., Völse, M., Scholten, S., & Margraf, J. (2016). Large Group Exposure Treatment: A Feasibility Study of Exposure Combined with Diaphragmatic Breathing in Highly Dental Fearful Individuals. Frontiers in psychology, 72007. https://doi.org/10.3389/fpsyg.2016.02007
Wannemueller, André, et al. "Large Group Exposure Treatment: A Feasibility Study of Exposure Combined with Diaphragmatic Breathing in Highly Dental Fearful Individuals." Frontiers in psychology vol. 7 (2016): 2007. doi: https://doi.org/10.3389/fpsyg.2016.02007
Wannemueller A, Jöhren HP, Borgstädt A, Bosch J, Meyers M, Völse M, Scholten S, Margraf J. Large Group Exposure Treatment: A Feasibility Study of Exposure Combined with Diaphragmatic Breathing in Highly Dental Fearful Individuals. Front Psychol. 2017 Jan 06;7:2007. doi: 10.3389/fpsyg.2016.02007. eCollection 2016. PMID: 28111556; PMCID: PMC5216840.
Copy Download .nbib Format: NLM
Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations.

PloS one

Hariharan P, D'Souza GA, Horner M, Morrison TM, Malinauskas RA, Myers MR.
PMID: 28594889
PLoS One. 2017 Jun 08;12(6):e0178749. doi: 10.1371/journal.pone.0178749. eCollection 2017.

A "credible" computational fluid dynamics (CFD) model has the potential to provide a meaningful evaluation of safety in medical devices. One major challenge in establishing "model credibility" is to determine the required degree of similarity between the model and...

Cite
Hariharan P, D'Souza GA, Horner M, et al. Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations. PLoS One. 2017;12(6):e0178749doi: 10.1371/journal.pone.0178749.
Hariharan, P., D'Souza, G. A., Horner, M., Morrison, T. M., Malinauskas, R. A., & Myers, M. R. (2017). Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations. PloS one, 12(6), e0178749. https://doi.org/10.1371/journal.pone.0178749
Hariharan, Prasanna, et al. "Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations." PloS one vol. 12,6 (2017): e0178749. doi: https://doi.org/10.1371/journal.pone.0178749
Hariharan P, D'Souza GA, Horner M, Morrison TM, Malinauskas RA, Myers MR. Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations. PLoS One. 2017 Jun 08;12(6):e0178749. doi: 10.1371/journal.pone.0178749. eCollection 2017. PMID: 28594889; PMCID: PMC5464577.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1261 entries